Exelixis, Inc. v. Teva Pharmaceutical Industries Limited et al
Exelixis, Inc. |
Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Limited and Teva Pharmaceuticals Development, Inc. |
1:2021cv00871 |
June 17, 2021 |
US District Court for the District of Delaware |
Richard G Andrews |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 |
None |
Docket Report
This docket was last retrieved on July 12, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
Pro Hac Vice Attorney Emily R. Whelan for Exelixis, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
Filing 10 WAIVER OF SERVICE returned executed by Exelixis, Inc.: For Teva Pharmaceuticals USA, Inc. waiver sent on 6/28/2021, answer due 8/27/2021. (Raucci, Anthony) |
Filing 9 WAIVER OF SERVICE returned executed by Exelixis, Inc.: For Teva Pharmaceuticals Development, Inc. waiver sent on 6/28/2021, answer due 8/27/2021. (Raucci, Anthony) |
Filing 8 WAIVER OF SERVICE returned executed by Exelixis, Inc.: For Teva Pharmaceutical Industries Limited waiver sent on 6/28/2021, answer due 8/27/2021. (Raucci, Anthony) |
Pro Hac Vice Attorney Timothy A. Cook, Lisa J. Pirozzolo, and Katherine P. Kieckhafer for Exelixis, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
Filing 7 MOTION for Pro Hac Vice Appearance of Attorney William F. Lee, Lisa J. Pirozzolo, Emily R. Whelan, Kevin S. Prussia, Timothy A. Cook, Katherine P. Kieckhafer, Kevin J. O'Brien, Benjamin I. Dach, Gerard A. Salvatore and Cristina Salcedo - filed by Exelixis, Inc.. (Raucci, Anthony) |
SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney William F. Lee, Lisa J. Pirozzolo, Emily R. Whelan, Kevin S. Prussia, Timothy A. Cook, Katherine P. Kieckhafer, Kevin J. O'Brien, Benjamin I. Dach, Gerard A. Salvatore and Cristina Salcedo, filed by Exelixis, Inc.. Signed by Judge Richard G. Andrews on 6/25/2021. (nms) |
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (mal) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Exelixis, Inc.. (mal) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,724,342 ;10,039,757 ;10,034,873. (mal) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about: May 4 and May 17, 2021. Date of Expiration of Patents: July 9, 2033 (Patent No. 9,724,342) and July 18, 2031 (Patent No. 10,039,757 and Patent No. 10,034,873). Thirty Month Stay Deadline: On or about: 11/4/2023. (mal) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3638460.) - filed by Exelixis, Inc.. (Attachments: #1 Exhibit A-C, #2 Civil Cover Sheet)(mal) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.